Approvals/TGA/MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine

Approved

STANDARD

MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b13ad4ef771f24ed
Product Name: MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine
Artg Id: 192696
Artg Name: MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2012-05-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0f14300c7aea0941ed8c682782983add.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5ff7a1fa14c1cdd4611d1a3bb15da166.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 31, 2025

Approval ID

b13ad4ef771f24ed

Type

Standard